Patents Assigned to Lifescan Scotland Limited
  • Patent number: 8460537
    Abstract: A method for determining an analyte concentration in blood is described that reduces the effects of hematocrit using a test strip attached to a test meter. The test strip includes a working electrode and a reference electrode. The test meter applies a test voltage between the working electrode and the reference electrode. After a user applies a blood sample containing an analyte onto the test strip, the test meter measures a plurality of test currents for a test time interval.
    Type: Grant
    Filed: September 3, 2009
    Date of Patent: June 11, 2013
    Assignee: LifeScan Scotland Limited
    Inventors: Stephen Patrick Blythe, Marco F Cardosi, Leanne Mills, Manuel Alvarez-Icaza, Emma Vanessa Jayne Day, Richard Michael Day, Christopher Philip Leach
  • Patent number: 8454533
    Abstract: Described and illustrated herein is an exemplary lancing device. The exemplary lancing device comprises: a first housing having spaced apart proximal and distal ends disposed along a longitudinal axis; a chassis disposed in the first housing in a fixed relationship with the first housing; a movable member disposed in the chassis and configured for movement along the longitudinal axis and in the first housing; a lancet coupled to the movable member; and a lancet depth adjustment member retained by both the first and chassis so that the lancet depth adjustment member is rotatable relative to both housings to provide for a plurality of stop surfaces to the movable member. Other embodiments and methods are also described.
    Type: Grant
    Filed: May 5, 2009
    Date of Patent: June 4, 2013
    Assignee: LifeScan Scotland Limited
    Inventors: Allan James Faulkner, Nicholas Foley, David Colin Crosland, Matthew James Young, Paul Trickett
  • Publication number: 20130095510
    Abstract: Described and illustrated herein are systems and exemplary methods of operating an analyte measurement system having a meter and a test strip. In one embodiment, the method may be achieved by applying a first test voltage between a reference electrode and a second working electrode and applying a second test voltage between the reference electrode and a first working electrode; measuring a first test current, a second test current, a third test current and a fourth test current at the second working electrode after a blood sample containing an analyte is applied to the test strip; measuring a fifth test current at the first working electrode; estimating a hematocrit-corrected analyte concentration from the first, second, third, fourth and fifth test currents; and annunciating the hematocrit-corrected analyte concentration.
    Type: Application
    Filed: March 30, 2011
    Publication date: April 18, 2013
    Applicant: LifeScan Scotland Limited
    Inventors: Michael Malecha, Adam Craggs
  • Patent number: 8388821
    Abstract: Description is provided herein for an embodiment of a method determining a hematocrit-corrected glucose concentration. The exemplary method includes providing a test strip having a reference electrode and a working electrode, wherein the working electrode includes a plurality of microelectrodes and is coated with at least an enzyme and a mediator.
    Type: Grant
    Filed: October 5, 2007
    Date of Patent: March 5, 2013
    Assignee: LifeScan Scotland Limited
    Inventors: Stephen Patrick Blythe, Marco F. Cardosi, Andrew Gill, Leanne Mills, Christopher Philip Leach
  • Publication number: 20130037421
    Abstract: A method and system is provided to allow for determination of substantially Hematocrit independent analyte concentration. In one example, an analyte measurement system is provided that includes a test strip and a test meter. The test strip includes a reference electrode and a working electrode, in which the working electrode is coated with a reagent layer. The test meter includes an electronic circuit and a signal processor. The electronic circuit applies a plurality of voltages to the reference electrode and the working electrode over respective durations. The signal processor is configured to determine a substantially hematocrit-independent concentration of the analyte from a plurality of current values as measured by the processor upon application of a plurality of test voltages to the reference and working electrodes over a plurality of durations interspersed with rest voltages lower than the test voltages being applied to the electrodes.
    Type: Application
    Filed: October 10, 2012
    Publication date: February 14, 2013
    Applicant: LifeScan Scotland Limited
    Inventor: LifeScan Scotland Limited
  • Patent number: 8348843
    Abstract: A meter is provided that includes an improved user interface that enables the user to take a specific action, leading them directly to data input options. Such a user interface could be used to input first selected information, such as whether a test was premeal or postmeal, immediately after receiving a result. Optionally, the user interface may include the ability to add an additional comment after inputting the first selected information. Provision of such a user interface would facilitate simpler capture of the first selected information each time the user performs a test, leading to an enhanced understanding of a patient's level of glycemic control. Designing a user interface to enable first selected information to be entered by a user directly after receiving a result is more likely to engage a patient by making it easy and simple to enter important information. This may enable capture of the information thought to be most pertinent e.g.
    Type: Grant
    Filed: July 7, 2011
    Date of Patent: January 8, 2013
    Assignee: LifeScan Scotland Limited
    Inventors: Stanley Alan Young, David William Taylor, Allan Orr, Cheryl Neary, Nicola Canning, Marc Daniel Stern
  • Patent number: 8343074
    Abstract: Devices for determining the concentration of an analyte in a fluid are provided. Also provided are systems and kits for use in practicing the subject methods.
    Type: Grant
    Filed: June 30, 2004
    Date of Patent: January 1, 2013
    Assignee: LifeScan Scotland Limited
    Inventors: Klaus Peter Weidenhaupt, James Moffat, Sebastian Böhm
  • Patent number: 8328719
    Abstract: A meter is provided that includes an improved user interface that enables the user to take a specific action, leading them directly to data input options. Such a user interface could be used to input first selected information, such as whether a test was premeal or postmeal, immediately after receiving a result. Optionally, the user interface may include the ability to add an additional comment after inputting the first selected information. Provision of such a user interface would facilitate simpler capture of the first selected information each time the user performs a test, leading to an enhanced understanding of a patient's level of glycemic control. Designing a user interface to enable first selected information to be entered by a user directly after receiving a result is more likely to engage a patient by making it easy and simple to enter important information. This may enable capture of the information thought to be most pertinent e.g.
    Type: Grant
    Filed: July 7, 2011
    Date of Patent: December 11, 2012
    Assignee: LifeScan Scotland Limited
    Inventors: Stanley Alan Young, David William Taylor, Allan Orr, Cheryl Neary, Nicola Canning, Marc Daniel Stern
  • Patent number: 8323467
    Abstract: A dual chamber, multi-analyte test strip has a first insulating layer, a first electrically conductive layer, with a first working electrode, disposed on the first insulating layer and a first patterned spacer layer positioned above the first electrically conductive layer. The first patterned spacer layer has a first sample-receiving chamber, with first and second end openings, defined therein that overlies the first working electrode. The test strip also includes a first counter/reference electrode layer that is exposed to the first sample receiving chamber and is in an opposing relationship to the first working electrode. The test strip further includes a counter/reference insulating layer disposed over the first counter/reference electrode layer and a second counter/reference electrode layer disposed on the counter/reference substrate. Also included in the test strip is a second patterned spacer layer that is positioned above the second counter/reference electrode layer.
    Type: Grant
    Filed: October 27, 2009
    Date of Patent: December 4, 2012
    Assignee: LifeScan Scotland Limited
    Inventors: Gavin MacFie, Graeme Webster, Marco F. Cardosi, Christopher Philip Leach, Steven Setford, Selwayan Saini
  • Publication number: 20120285837
    Abstract: An electrochemical-based analytical test strip for the determination of an analyte (e.g., glucose) in a bodily fluid sample (such as a whole blood sample) includes an electrically insulating base layer and a patterned conductor layer (for example, a gold patterned conductor layer) disposed over the electrically-insulating layer. The patterned conductor layer includes at least one electrode with the electrode having electrochemically inert areas and an electrochemically active area(s). Moreover, the electrochemically inert areas and electrochemically active area(s) are of a predetermined size and a predetermined distribution such that electrochemical response of the electrode during use of the electrochemical-based analytical test strip is essentially equivalent to a predetermined electrochemical response.
    Type: Application
    Filed: July 20, 2012
    Publication date: November 15, 2012
    Applicant: LifeScan Scotland Limited
    Inventors: Gavin MACFIE, Craig Redpath, James lain Rodgers, Neil Whitehead
  • Patent number: 8293096
    Abstract: A method and system is provided to allow for determination of substantially Hematocrit independent analyte concentration. In one example, an analyte measurement system is provided that includes a test strip and a test meter. The test strip includes a reference electrode and a working electrode, in which the working electrode is coated with a reagent layer. The test meter includes an electronic circuit and a signal processor. The electronic circuit applies a plurality of voltages to the reference electrode and the working electrode over respective durations. The signal processor is configured to determine a substantially hematocrit-independent concentration of the analyte from a plurality of current values as measured by the processor upon application of a plurality of test voltages to the reference and working electrodes over a plurality of durations interspersed with rest voltages lower than the test voltages being applied to the electrodes.
    Type: Grant
    Filed: January 22, 2010
    Date of Patent: October 23, 2012
    Assignee: LifeScan Scotland Limited
    Inventors: Marco F. Cardosi, Stephen Patrick Blythe, Matthew Finch, Arlene Thompson, Nina Antonia Naylor, Eric Jason Bailey, Michael Patrick Dolan, Gretchen Anderson, Lorraine Comstock, Mary McEvoy, Thomas Sutton, Richard Michael Day, Leanne Mills, Emma Vanessa Jayne Day, Christopher Philip Leach
  • Publication number: 20120199497
    Abstract: An electrochemical-based analytical test strip for the determination of an analyte (such as glucose) in a bodily fluid sample (e.g., a whole blood sample) includes a substrate, at least one working electrode disposed on the substrate, a sample-soluble enzymatic reagent layer disposed above the working electrode, a diffusion-controlling layer (DCL) disposed between the at least one working electrode and the sample-soluble enzymatic reagent layer; and a sample-receiving chamber. In addition, the sample-soluble enzymatic reagent layer is configured and constituted for operable solubility in a bodily fluid sample applied to the electrochemical-based analytical test strip and received in the sample-receiving chamber and for electrochemical enzymatic reaction with an analyte in the bodily fluid sample.
    Type: Application
    Filed: February 7, 2011
    Publication date: August 9, 2012
    Applicant: LifeScan Scotland Limited
    Inventors: Zuifang Liu, Marco F. Cardosi, Christopher Philip Leach, Scott Sloss
  • Publication number: 20110290668
    Abstract: An electrochemical-based analytical test strip for the determination of an analyte (such as glucose) in a bodily fluid sample (for example, whole blood) includes an electrically insulating base layer, a patterned conductor layer disposed over the electrically-insulating layer, and a patterned insulation layer, with an electrode exposure window therethrough, disposed over the patterned conductor layer. The patterned conductive layer of the electrochemical-based analytical test strip includes at least one working electrode and a counter/reference electrode. In addition, at least a portion of the electrode exposure window is configured to expose a working electrode exposed portion and a counter/reference electrode exposed portion, with the working electrode exposed portion being rectangular in shape and the counter/reference electrode exposed portion being one of a crossroads shape and an at least six-sided portion of a crossroads shape.
    Type: Application
    Filed: May 27, 2010
    Publication date: December 1, 2011
    Applicant: LifeScan Scotland Limited
    Inventors: James MOFFAT, Lynsey Whyte, Robert Marshall, Steven Setford
  • Publication number: 20110284393
    Abstract: An electrochemical-based analytical test strip for the determination of an analyte (e.g., glucose) in a bodily fluid sample (such as a whole blood sample) includes an electrically insulating base layer and a patterned conductor layer (for example, a gold patterned conductor layer) disposed over the electrically-insulating layer. The patterned conductor layer includes at least one electrode with the electrode having electrochemically inert areas and an electrochemically active area(s). Moreover, the electrochemically inert areas and electrochemically active area(s) are of a predetermined size and a predetermined distribution such that electrochemical response of the electrode during use of the electrochemical-based analytical test strip is essentially equivalent to a predetermined electrochemical response.
    Type: Application
    Filed: May 19, 2010
    Publication date: November 24, 2011
    Applicant: LifeScan Scotland Limited
    Inventors: Gavin MACFIE, Craig Redpath, James Iain Rodgers, Neil Whitehead
  • Patent number: 8057753
    Abstract: A test strip ejection mechanism, for use with a test strip receiving port and a test strip, includes a framework, an elongated shape memory alloy (SMA) strip (e.g., a SMA wire), a slider, and a heating module. The SMA strip has first and second ends that are attached to the framework and exhibits a solid state transition temperature. The slider is configured to travel along the framework. The heating module is configured to heat the SMA strip from a temperature below the solid state transition temperature to a temperature above the solid state transition temperature. Moreover, the SMA strip and slider are configured such that the slider travels along the framework under an applied force exerted on the slider by the SMA strip as the shape memory strip is heated from a temperature below the solid state transition temperature to a temperature above the solid state temperature by the heating module.
    Type: Grant
    Filed: February 4, 2010
    Date of Patent: November 15, 2011
    Assignee: LifeScan Scotland Limited
    Inventors: Marco DeAngeli, Luca Valsecchi
  • Publication number: 20110270063
    Abstract: A meter is provided that includes an improved user interface that enables the user to take a specific action, leading them directly to data input options. Such a user interface could be used to input first selected information, such as whether a test was premeal or postmeal, immediately after receiving a result. Optionally, the user interface may include the ability to add an additional comment after inputting the first selected information. Provision of such a user interface would facilitate simpler capture of the first selected information each time the user performs a test, leading to an enhanced understanding of a patient's level of glycemic control. Designing a user interface to enable first selected information to be entered by a user directly after receiving a result is more likely to engage a patient by making it easy and simple to enter important information. This may enable capture of the information thought to be most pertinent e.g.
    Type: Application
    Filed: July 7, 2011
    Publication date: November 3, 2011
    Applicant: LifeScan Scotland Limited
    Inventors: Stanley Alan YOUNG, David William TAYLOR, Allan ORR, Cheryl NEARY, Nicola CANNING, Marc Daniel STERN
  • Publication number: 20110263959
    Abstract: A meter is provided that includes an improved user interface that enables the user to take a specific action, leading them directly to data input options. Such a user interface could be used to input first selected information, such as whether a test was premeal or postmeal, immediately after receiving a result. Optionally, the user interface may include the ability to add an additional comment after inputting the first selected information. Provision of such a user interface would facilitate simpler capture of the first selected information each time the user performs a test, leading to an enhanced understanding of a patient's level of glycemic control. Designing a user interface to enable first selected information to be entered by a user directly after receiving a result is more likely to engage a patient by making it easy and simple to enter important information. This may enable capture of the information thought to be most pertinent e.g.
    Type: Application
    Filed: July 7, 2011
    Publication date: October 27, 2011
    Applicant: LifeScan Scotland Limited
    Inventors: Stanley Alan YOUNG, David William Taylor, Allan Orr, Cheryl Neary, Nicola Canning, Marc Daniel Stern
  • Patent number: 8025788
    Abstract: A method for manufacturing an enzymatic reagent ink for use in analytical test strips (such as electrochemical-based analytical test strips configured for the determination of glucose in blood) includes determining a first relationship between wetability of a representative hydrophobic silica material (e.g., a hydrophobic fumed silica material) and at least a first calibration characteristic (for example, a calibration slope) of an analytical test strip that includes an enzymatic reagent ink containing the representative hydrophobic silica material. In the method, the first relationship defines a minimum wetability that provides an acceptable first calibration characteristic.
    Type: Grant
    Filed: April 24, 2009
    Date of Patent: September 27, 2011
    Assignee: LifeScan Scotland Limited
    Inventors: Marco F. Cardosi, Michael O'Connell
  • Patent number: D674181
    Type: Grant
    Filed: March 2, 2012
    Date of Patent: January 15, 2013
    Assignee: LifeScan Scotland Limited
    Inventors: Allan Faulkner, Nick Foley, Jonny Nelson, Simon Salter, Paul Trickett
  • Patent number: D684491
    Type: Grant
    Filed: December 21, 2012
    Date of Patent: June 18, 2013
    Assignee: LifeScan Scotland Limited
    Inventors: Ivan Confield, Allan Orr, Ryan Magennis, Nick Foley, Giorgio Castellari, Maurizio Volpe, Roberto Beretta, Fabio Foleghi, Paul Trickett, James Glencross